Molecular Diagnostics Market 2020 Size, Share, growth and Top key Players- Abbott, QIAGEN, Hologic, Inc., BD and more

The global molecular diagnostics market is projected to grow with rising technological developments in molecular diagnostic techniques. These advancements are intended to offer higher accuracy, cost-effectiveness, and portability which further drives the market. This information was published by Fortune Business Insights in a report, titled "Molecular Diagnostics Market Size, Share and Global Trend By Product Type (Instruments Reagents & Consumables), Application (Infectious Disease, Blood Screening, Histology & Oncology), Technique (Hospitals Amplification, Hybridization & Sequencing Techniques), End User (Hospitals, Clinical & Pathology Labs) and Geography Forecast till 2025" offering insights on factors influencing growth. The global market covered a value of US$ 8012.7 Mn in the year 2017 and is projected to reach US$ 13873.6 Mn by 2025. As per the report, the global market is expected to garner a healthy CAGR of 7.1% throughout the forecast period.

Request A Sample Copy - Molecular Diagnostics Market Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/molecular-diagnostics-market-100086

Leading Players operating in the Molecular Diagnostics Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

o bioM�rieux SA.
o BD
o Danaher
o Grifols, S.A.
o Hologic Inc.
o Novartis AG
o QIAGEN
o Siemens Healthcare GmbH
o F. Hoffmann-La Roche Ltd.

North America Continues to Maintain Its Stronghold until 2025

"Well-established healthcare infrastructure, combined with the rising incidence of cancer is helping the market grow in North America," stated a lead analyst at Fortune Business Insights. "Developed healthcare systems further helps in the easy availability and accessibility of advanced instruments such as molecular diagnostics. In 2017, this regional market was valued at US$ 3639.4 Mn and is likely to lead the global landscape through the forecast period. The rising collaborations and association between research hospitals and academic institutions encourages growth of the market in this region. Both the bodies are involving in continuous discussions for process improvements in molecular diagnosis. The market in Europe is also expected to witness considerable growth with growing emphasis on clinical microbiology and hospital research organizations. This is mainly done to increase the number of molecular diagnostic techniques. Rapidly developing healthcare infrastructure and rising investments in research and development activities are factors responsible for creating good growth opportunities.

Click here to get the Details of Molecular Diagnostics Market. Please visit: https://www.fortunebusinessinsights.com/industry-reports/molecular-diagnostics-market-100086

Transformation in Healthcare May Lead to Innovative Molecular Diagnostic Systems
The evolution of molecular diagnosis over the years has given birth to different molecular diagnostic tests. These tests help to detect specific RNA or DNA sequences. In addition to this, they help to get an understanding if these sequences are associated with diseases or not. With the rapid transformation of healthcare, innovative molecular diagnostic tests are likely to introduce in the coming years. This will further transform the molecular biology field. Other factors driving the molecular diagnostic market are rising demand for healthcare facilities and personalized medicine. Furthermore, several favourable policies by governments with an aim to encourage care diagnosis and increase awareness about diagnostic procedures drives the market.

Detailed Table of Content:

1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1 Porter's five forces analysis
4.2 Top 3 players working in market space
4.3 Key developments (Merger, Acquisitions, etc.)
4.4 Technological Advancements
5. Global Molecular Diagnostics Market Analysis, Insights and Forecast, 2014-2025
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast - By Product Type
5.2.1 Instruments
5.2.2 Reagents & Consumables
5.3. Market Analysis, Insights and Forecast - By Application
5.3.1 Infectious Disease
5.3.2 Blood Screening
5.3.3 Histology
5.3.4 Oncology
5.3.5 Others
5.4 Market Analysis, Insights and Forecast - By Technique
5.4.1 Amplification Techniques
5.4.2 Hybridization Techniques
5.4.3 Sequencing Techniques
5.4.4 Others
5.5. Market Analysis, Insights and Forecast - By End User
5.5.1 Clinical & Pathology Labs
5.5.2 Hospitals
5.5.3 Others
5.6. Market Analysis, Insights and Forecast - By Region
5.6.1 North America
5.6.2 Europe
5.6.3 Asia Pacific
5.6.4 Middle East & Africa
5.6.5 Latin America
6. North America Molecular Diagnostics Market Analysis, Insights and Forecast, 2014-2025
6.1. Key Findings / Summary
6.2. Market Analysis - By Product Type
6.2.1 Instruments
6.2.2 Reagents & Consumables
6.3. Market Analysis - By Application
6.3.1 Infectious Disease
6.3.2 Blood Screening
6.3.3 Histology
6.3.4 Oncology
6.3.5 Others
6.4. Market Analysis - By Technique
6.4.1 Amplification Techniques
6.4.2 Hybridization Techniques
6.4.3 Sequencing Techniques
6.4.4 Others
6.5. Market Analysis - By End User
6.5.1 Clinical & Pathology Labs
6.5.2 Hospitals
6.5.3 Others
6.6. Market Analysis - By Country
6.6.1 U.S.
6.6.2 Canada

Have Any Query? Ask Our Research Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/molecular-diagnostics-market-100086

Report Focus:

o Extensive product offerings
o Customer research services
o Robust research methodology
o Comprehensive reports
o Latest technological developments
o Value chain analysis
o Potential Molecular Diagnostics Market opportunities
o Growth dynamics
o Quality assurance
o Post-sales support
o Regular report updates

Reasons to Purchase this Report:

o Comprehensive analysis of the Molecular Diagnostics Market growth drivers, obstacles, opportunities, and other related challenges.
o Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
o Identifies market restraints and boosters.
o Identifies all the possible segments present in the market to aid organizations in strategic business planning.

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.